BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 22, 2013
View Archived Issues
Merus Labs International agrees to promote and distribute drug for overactive bladder in Europe
Read More
Novel sensor for the rapid intraoperative detection of complete tumor resection
Read More
Generation of a human anticancer immune response using a dendritic cell-based vaccine
Read More
Uncovering a causative link between endocannabinoid-mediated inflammation and type 2 diabetes
Read More
PlantForm secures funding for biosimilar breast cancer product
Read More
VAL-083 dose escalation to be accelerated in phase I/II trial
Read More
Pharmacokinetic study of onapristone initiated
Read More
Lilly presents a novel series of selective CB2 agonists
Read More
Lightlake Therapeutics and NIH partner to develop intranasal naloxone for opioid overdose
Read More
Catabasis begins phase II trial of CAT-2003 in hypertriglyceridemia and hypercholesterolemia
Read More
Oramed recruits for new ORMD-0801 trial
Read More
Incyte discloses topline results from phase II proof-of-concept ruxolitinib study
Read More
FDA allows marketing of VITEK MS system
Read More
ISCO and Duke University sign research agreement
Read More
New human influenza virus monoclonal antibodies disclosed
Read More
Mount Sinai and Exosome Diagnostics enter collaboration
Read More
Galectin Therapeutics raises funds in private placement of restricted stock
Read More
SBI Biotech reports new antibodies for autoimmune disorders
Read More
Nicotinic acetylcholine receptor ligands patented by Targecept
Read More
Memorial Sloan-Kettering Cancer Center begins phase I trial of radiolabeled dasatinib derivative
Read More
Novel adenoviral vectors for malaria disclosed by GenVec
Read More
Navidea receives NIH grant, enters into agreement with Siemens' PETNET Solutions for imaging agent
Read More